BioWorld

May 6, 2004

View Archived Issues

IntraBiotics Raises $39M To Advance Iseganan In Clinic

Enabling IntraBiotics Pharmaceuticals Inc. to ramp up its clinical programs for iseganan, the company raised $39 million gross in a public stock offering Wednesday. (BioWorld Today) Read More

Biolex Grows MAb Capabilities Through Acquisition Of Epicyte

Read More

FDA's Annual Report States Goals For PDUFA III Reached

Read More

TriMed Focuses On Developing MAA Protein For Multiple Uses

Read More

Other News To Note

Read More

Appointments And Advancements

Read More